RAPISART-AM is a dual-action antihypertensive combining an ARB with a calcium channel blocker for enhanced blood pressure control in resistant hypertension. Telmisartan provides vasodilation and cardiovascular protection by blocking angiotensin II receptors, while amlodipine relaxes vascular smooth muscle to further reduce blood pressure. This combination is particularly effective for patients who do not achieve target blood pressure with monotherapy, offering improved efficacy while maintaining a favorable safety profile. RAPISART-AM is ideal for managing moderate to severe hypertension, reducing the risk of cardiovascular events, and improving patient adherence with once-daily dosing.
RAPISART-AM: Telmisartan + Amlodipine for Resistant Hypertension
Category: Tablets
Packaging: 10x10 Alu Alu
Composition: Telmisartan IP 40mg + Amlodipine Besylate IP 5mg
Therapeutic Class: Antihypertensive
Strength: 40mg + 5mg per tablet
MRP: ₹1500.00
SCHEDULE H PRESCRIPTION DRUG - WARNING:To be sold by retail on the prescription of a Registered Medical Practitioner only.
Request Info Introduction
Uses & Indications
- Resistant or moderate hypertension
- Angina pectoris relief
- Cardiovascular protection
- Post-MI management
- Chronic kidney disease with hypertension
Contraindications
- Pregnancy
- Cardiogenic shock
- Hypersensitivity
Side Effects
The side effects listed below may occur with the use of this medication. However, not all individuals experience these effects.
- Ankle edema (common)
- Headache
- Fatigue
- Palpitations (rare)
- Flushing
Precautions
- Avoid grapefruit juice
- Monitor ankle edema
- Check BP regularly
Safety Advice & Precautions
- Take at same time daily
- Monitor blood pressure regularly
- Avoid grapefruit juice
- Rise slowly to prevent dizziness
- Report persistent ankle swelling
- Inform doctor of liver disease
Storage Conditions
Store at temperature not exceeding 25°C. Protect from light.
Shelf Life & Expiry
36 months
Frequently Asked Questions
How does RAPISART-AM help with AM combination?
Combination therapy in single tablet
How does the combination tablet format of RAPISART-AM support better compliance?
Single tablet simplifies once-daily dosing
What are the individual active components of RAPISART-AM?
ARB plus thiazide diuretic
What precautions should I take when starting treatment with RAPISART-AM?
Often used for initial BP management
Medical Disclaimer
This product information is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare professional before starting any new medication or changing your dosage. Rapid Pharmaceuticals is not responsible for any adverse effects resulting from the misuse of this medication.
